Protective effect of jolkinolide B on LPS-induced mouse acute lung injury

International Immunopharmacology

Volumn 26, Issue 1, 2015, Pages 119-124

  Yang, Hailing ^a   Li, Yan ^a   Huo, Pengfei ^a   Li, Xiao Ou ^b   Kong, Daliang ^a   Mu, Wei ^a   Fang, Wei ^a   Li, Lingxia ^a   Liu, Ning ^a   Fang, Ling ^a   Li, Hongjun ^a   He, Chengyan ^a  

^a JILIN UNIVERSITY   (China)

^b Tumor Hospital of Jilin Province   (China)

Author keywords

Acute lung injury; Jolkinolide B; MAPK; NF B

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; DITERPENOID; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; JOLKINOLIDE B; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MYELOPEROXIDASE; PROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; DITERPENE; LIPOPOLYSACCHARIDE, E COLI O55-B5;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HISTOPATHOLOGY; INFLAMMATORY CELL; LUNG EDEMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; CHEMICALLY INDUCED; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; EUPHORBIA; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; ORGAN SIZE; PATHOLOGY; PLANT ROOT; VASCULARIZATION; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CYTOKINES; DISEASE MODELS, ANIMAL; DITERPENES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EUPHORBIA; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE, INBRED C57BL; ORGAN SIZE; PLANT ROOTS;

EID: 84925735855     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.03.021     Document Type: Article

References (25)

1. G.D. Rubenfeld, E. Caldwell, E. Peabody, J. Weaver, D.P. Martin, M. Neff, E.J. Stern, and L.D. Hudson Incidence and outcomes of acute lung injury N. Engl. J. Med. 353 2005 1685 1693
2. M.A. Matthay, and G.A. Zimmerman Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management Am. J. Respir. Cell Mol. Biol. 33 2005 319 327
3. T. Eckle, E.M. Kewley, K.S. Brodsky, E. Tak, S. Bonney, M. Gobel, D. Anderson, L.E. Glover, A.K. Riegel, S.P. Colgan, and H.K. Eltzschig Identification of hypoxia-inducible factor HIF-1A as transcriptional regulator of the A2B adenosine receptor during acute lung injury J. Immunol. 192 2014 1249 1256
4. K. Fu, T. Piao, M. Wang, J. Zhang, J. Jiang, X. Wang, and H. Liu Protective effect of catalpol on lipopolysaccharide-induced acute lung injury in mice Int. Immunopharmacol. 23 2014 400 406
5. X. Chen, X. Yang, T. Liu, M. Guan, X. Feng, W. Dong, X. Chu, J. Liu, X. Tian, X. Ci, H. Li, J. Wei, Y. Deng, X. Deng, G. Chi, and Z. Sun Kaempferol regulates MAPKs and NF-kappaB signaling pathways to attenuate LPS-induced acute lung injury in mice Int. Immunopharmacol. 14 2012 209 216
6. R.J. Szarka, N. Wang, L. Gordon, P.N. Nation, and R.H. Smith A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation J. Immunol. Methods 202 1997 49 57
7. Z. San, Y. Fu, W. Li, E. Zhou, Y. Li, X. Song, T. Wang, Y. Tian, Z. Wei, M. Yao, Y. Cao, and N. Zhang Protective effect of taraxasterol on acute lung injury induced by lipopolysaccharide in mice Int. Immunopharmacol. 19 2014 342 350
8. L. Zhang, Y. Ren, C. Yang, Y. Guo, X. Zhang, G. Hou, X. Guo, N. Sun, and Y. Liu Wogonoside ameliorates lipopolysaccharide-induced acute lung injury in mice Inflammation 37 2014 2006 2012
9. Y. Tang, Y. Chen, Z. Chu, B. Yan, and L. Xu Protective effect of cryptotanshinone on lipopolysaccharide-induced acute lung injury in mice Eur. J. Pharmacol. 723 2014 494 500
10. N. Niu, B. Li, Y. Hu, X. Li, J. Li, and H. Zhang Protective effects of scoparone against lipopolysaccharide-induced acute lung injury Int. Immunopharmacol. 23 2014 127 133
11. X. Ma, Y. Liu, Y. Zhang, X. Yu, W. Wang, and D. Zhao Jolkinolide B inhibits RANKL-induced osteoclastogenesis by suppressing the activation NF-kappaB and MAPK signaling pathways Biochem. Biophys. Res. Commun. 445 2014 282 288
12. T. Uto, G.W. Qin, O. Morinaga, and Y. Shoyama 17-Hydroxy-jolkinolide B, a diterpenoid from Euphorbia fischeriana, inhibits inflammatory mediators but activates heme oxygenase-1 expression in lipopolysaccharide-stimulated murine macrophages Int. Immunopharmacol. 12 2012 101 109
13. L.C. Pan, X.H. Xu, N.N. Zhang, N. Liu, D.L. Wu, Y. Wang, Q.S. Peng, M. Vandenplas, H.B. Wang, and W.C. Sun HJB-1, a 17-hydroxy-jolkinolide B derivative, inhibits LPS-induced inflammation in mouse peritoneal macrophages Int. Immunopharmacol. 21 2014 474 480
14. W.C. Sun, J.N. Moore, D.J. Hurley, M.L. Vandenplas, J. Linden, Z. Cao, and T.F. Murray Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes Vet. Immunol. Immunopathol. 121 2008 91 100
15. Y. Li, X.L. Liu, Z.G. Cai, and S.X. Zhang LC-ESI-MS/MS analysis and pharmacokinetics of jolkinolide B, a potential antitumor active component isolated from Euphorbia fischeriana, in rat plasma Biomed. Chromatogr. 28 2014 193 196
16. J.H. Wang, K. Zhang, H.Y. Niu, L.H. Shu, D.M. Yue, D. Li, and P. He Jolkinolide B from Euphorbia fischeriana Steud induces in human leukemic cells apoptosis via JAK2/STAT3 pathways Int. J. Clin. Pharmacol. Ther. 51 2013 170 178
17. L.W. Soromou, N. Chen, L. Jiang, M. Huo, M. Wei, X. Chu, F.M. Millimouno, H. Feng, Y. Sidime, and X. Deng Astragalin attenuates lipopolysaccharide-indcF-kappaB signaling pathway Biochem. Biophys. Res. Commun. 419 2012 256 261
18. S. Herold, N.M. Gabrielli, and I. Vadasz Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction Am. J. Physiol. Lung Cell. Mol. Physiol. 305 2013 L665 681
19. D. Liang, Y. Sun, Y. Shen, F. Li, X. Song, E. Zhou, F. Zhao, Z. Liu, Y. Fu, M. Guo, N. Zhang, Z. Yang, and Y. Cao Shikonin exerts anti-inflammatory effects in a murine model of lipopolysaccharide-induced acute lung injury by inhibiting the nuclear factor-kappaB signaling pathway Int. Immunopharmacol. 16 2013 475 480
20. E.H. Joh, W. Gu, and D.H. Kim Echinocystic acid ameliorates lung inflammation in mice and alveolar macrophages by inhibiting the binding of LPS to TLR4 in NF-kappaB and MAPK pathways Biochem. Pharmacol. 84 2012 331 340
21. M. Bhatia, and S. Moochhala Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome J. Pathol. 202 2004 145 156
22. S. Mukhopadhyay, J.R. Hoidal, and T.K. Mukherjee Role of TNFalpha in pulmonary pathophysiology Respir. Res. 7 2006 125
23. J.J. Grailer, B.A. Canning, M. Kalbitz, M.D. Haggadone, R.M. Dhond, A.V. Andjelkovic, F.S. Zetoune, and P.A. Ward Critical role for the NLRP3 inflammasome during acute lung injury J. Immunol. 192 2014 5974 5983
24. A. Banerjee, and S. Gerondakis Coordinating TLR-activated signaling pathways in cells of the immune system Immunol. Cell Biol. 85 2007 420 424
25. D.B. Reddy, and P. Reddanna Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages Biochem. Biophys. Res. Commun. 381 2009 112 117